Cervical cancer screening continues to limit provision of contraception.
OBJECTIVE
Balancing needs for contraception and cervical cancer screening is challenging for clinicians. We assessed US obstetrician/gynecologists' practices regarding requirement of Pap testing before prescribing oral contraceptive or emergency contraceptive pills.


METHODS
Questionnaires structured as clinical vignettes describing women desiring contraception with different risks of cervical dysplasia were mailed to a national sample of 355 obstetrician/gynecologists.


RESULTS
A minority (3%) of the 185 obstetrician/gynecologists who responded would refill 12 months of oral contraceptives without requiring Pap testing. However, most would provide a limited supply of oral contraceptives until Pap testing could be performed. A substantial proportion (11-16%) would refuse to prescribe emergency contraception to women who they felt required Pap testing. Younger physicians, those practicing in academic settings and those who follow American Cancer Society guidelines were more willing to prescribe contraceptives without Pap testing.


CONCLUSIONS
Cervical cancer screening continues to limit prescription of routine and emergency contraception by many US obstetrician/gynecologists.
Schwarz
Eleanor Bimla
EB
General Internal Medicine Section, Department of Medicine, University of California, San Francisco (UCSF), San Francisco, CA 94121, USA. schwarz@medicine.ucsf.edu
Saint
Mona
M
Gildengorin
Ginny
G
Weitz
Tracy A
TA
Stewart
Felicia H
FH
Sawaya
George F
GF
D003267:Contraception / Q000706:statistics & numerical data; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003281:Contraceptives, Postcoital; D011307:Drug Prescriptions; D005260:Female; D006801:Humans; D008875:Middle Aged; D010820:Physicians / Q000941:ethics; D010818:Practice Patterns, Physicians'; D011795:Surveys and Questionnaires; D002578:Uterine Cervical Dysplasia; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control; D014626:Vaginal Smears
D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003281:Contraceptives, Postcoital